What is PDS Biotechnology Corp (PDSB) stock price today?

PDS Biotechnology Corp (PDSB) currently trades at $0.97 per share. The stock has a market capitalization of $60.28M and a P/E ratio of —x.

Is PDSB stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, PDS Biotechnology Corp has a Smart Value Score of 16/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is -6.65.

Is PDS Biotechnology Corp financially healthy?

PDS Biotechnology Corp's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of -6.65 places it in the distress.

PDSB

PDS Biotechnology Corp

NASDAQ: PDSB · HEALTHCARE · BIOTECHNOLOGY

$0.97

+1.32% today

Updated 2026-04-30

Market cap

$60.28M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.74

Dividend yield

—

52W range

$1 – $2

Volume

0.8M

Market cap

$60.28M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.74

Dividend yield

—

52W range

$1 – $2

Volume

0.8M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.5

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-6.7

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$7.50

+670.81%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -6.65 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-3.70M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-40.85M	$-42.94M	$-37.61M	$-34.50M	$-7.56M
EPS	—	—	—	—	$-0.74
Free cash flow	$-25.71M	$-33.64M	$-35.06M	$-27.75B	$-3.70M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PDSB	$60.28M	16	4.3	3.0	5.0	4.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

PDS Biotechnology Corp trades at $0.97. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -6.65, it sits in the distress.

Frequently asked questions

What is PDS Biotechnology Corp's stock price?

PDS Biotechnology Corp (PDSB) trades at $0.97.

Is PDS Biotechnology Corp overvalued?

Smart Value Score 16/100 (Grade F, Strong Sell).

What is the price target of PDS Biotechnology Corp (PDSB)?

The analyst target price is $7.50, representing +670.8% upside from the current price of $0.97.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

-6.65 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.pdsbiotech.com

Quick metrics

P/S ratio—

ROE-244.20%

Beta1.19

50D MA$0.80

200D MA$0.94

Shares out0.06B

Float0.05B

Short ratio—

Avg volume0.8M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

PDSB vs LLY →PDSB vs JNJ →PDSB vs ABBV →Stock screener →